EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $33,000 | -21.4% | 1,624 | -5.8% | 0.01% | -40.0% |
| Q3 2020 | $42,000 | -4.5% | 1,724 | -7.9% | 0.01% | -16.7% |
| Q2 2020 | $44,000 | +37.5% | 1,872 | +2.0% | 0.01% | +9.1% |
| Q1 2020 | $32,000 | -5.9% | 1,836 | 0.0% | 0.01% | +22.2% |
| Q4 2019 | $34,000 | -5.6% | 1,836 | -8.2% | 0.01% | -10.0% |
| Q3 2019 | $36,000 | -18.2% | 2,000 | +1.0% | 0.01% | -16.7% |
| Q2 2019 | $44,000 | 0.0% | 1,980 | +7.6% | 0.01% | 0.0% |
| Q1 2019 | $44,000 | +37.5% | 1,840 | +13.2% | 0.01% | +9.1% |
| Q4 2018 | $32,000 | +6.7% | 1,626 | 0.0% | 0.01% | +22.2% |
| Q3 2018 | $30,000 | -16.7% | 1,626 | 0.0% | 0.01% | -18.2% |
| Q2 2018 | $36,000 | -99.9% | 1,626 | 0.0% | 0.01% | -8.3% |
| Q1 2018 | $35,994,000 | -21.1% | 1,626 | +8.4% | 0.01% | -20.0% |
| Q4 2017 | $45,600,000 | – | 1,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |